Found 156 matching trials
Rituximab in Systemic Sclerosis PHASE2 The purpose of this study is to determine whether rituximab is effective in...
Show More Learn More & Join Trial
Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis PHASE2 This study will assess the efficacy and safety of different treatment regim...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkin's Lymphoma (NHL) PHASE3 This is a Phase III, multicenter, global, clinical study of an investigatio...
Show More Location
Multiple Locations
Learn More & Join Trial
Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients PHASE3 This is a phase 3, multicenter, randomized, double-blind, placebo-controlle...
Show More Status
Active Not Recruiting
Location
MorphoSys Research Site
Learn More & Join Trial
Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia PHASE3 The primary objective of this study is to evaluate the progression-free sur...
Show More Location
St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center
Learn More & Join Trial
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. PHASE3 The participants of this study would have relapsed/refractory follicular ly...
Show More Status
Active Not Recruiting
Location
Southern Cancer Center
Learn More & Join Trial
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus PHASE2 This is a Phase II/III, randomized, double-blind, placebo-controlled, multi...
Show More Location
Univ of Alabama School of Med; Clinical Immun Rheumatology
Learn More & Join Trial
Belimumab and Rituximab Combination Therapy for the Treatment of Diffuse Cutaneous Systemic Sclerosis PHASE2 This is a 52 week, single center, randomized, double-blind, placebo-control...
Show More Location
Hospital for Special Surgery
Learn More & Join Trial
Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of ANCA-associated Vasculitis (TTCAAVREM) PHASE4 This study is a prospective, open-labelled, randomized, controlled, single-...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Rituximab to Treat Neuropathy With Anti-MAG Antibodies PHASE2 This study will test the safety and effectiveness of the drug Rituximab in ...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial